Health & Biotech

Teva Pharmaceutical Industries (NYSE: TEVA) — 1901 Jerusalem roots; modern form 1976 merger under Eli Hurvitz. Copaxone (1997 FDA approval) was the wo…

Compugen (Nasdaq: CGEN; TASE: CGEN) — Israeli immuno-oncology and predictive drug-discovery pioneer. Founded 1993 by Eli Mintz, Simchon Faigler, Amir…

Teva paid $40.5 billion for Allergan Generics in 2016 and watched approximately $50 billion in market value evaporate. Eight years and three CEOs late…

Israel's one pharmaceutical giant nearly destroyed itself reaching for scale. Its recovery is real — but it is a story about surviving the generics mo…

Maccabi serves ~2.4 million Israelis and runs the country's largest biobank through KSM. The most commercially accessible HMO partnership platform in…

The second-largest of Israel's four statutory health funds, covering roughly a quarter of the population and home to the KSM Research Institute medica…

Tofes 17 is the authorization form Israel's four health funds issue for external medical services. It is the commercial gate that decides which foreig…

The legally defined package of medical services, drugs, and devices that every Israeli resident is entitled to receive under the country's 1995 Nation…

Meuhedet Health Services is Israel's third-largest statutory health fund. Approximately 1.3 million members, ~250 clinics, ~4,000 physicians. Founded…